Brief: Jubilant Ingrevia Enters Agreement With Remidex Pharma For Acquisition Of 100% Stake
13/03/2026 15:27
March 13 (Reuters) - Jubilant Ingrevia Ltd JUBN.NS: AGREEMENT WITH REMIDEX PHARMA FOR ACQUISITION OF 100% STAKE DEAL FOR 165 MILLION RUPEES Source text: ID:nnAZN4SL6TU Further company coverage: JUBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Jubilant Ingrevia
See all newsBrief: Jubilant Ingrevia Says Board Approves Acquisition Of 40% Strategic Equity Stake In Zettaone Through Subsidiary
India's Jubilant Ingrevia rises as Kotak sees growth outweighing contract risks
Brief: Jubilant Ingrevia To Buy 40% Stake In Zettaone Technologies India For 1.89 Billion Rupees
Brief: Jubilant Ingrevia June-Quarter Consol Net Profit 1.06 Billion Rupees
Brief: Jubilant Ingrevia March-Quarter Consol Net Profit 864.4 Million Rupees